January   | View Newsletter

February | View Newsletter

March | View Newsletter

Includes:

• Diagnoses of Cancer Decline in the US

• Cleveland Clinic Unveils ‘Top 10’ Medical Innovations for 2009

• Antidiabetic Drugs Linked to Lower Risk of Prostate Cancer

• Index of Articles Appearing in the 2008 Us TOO HotSheets

• Doc Moyad’s “What Works and What Is Worthless Column”— The JUPITER trial

• PSA Doubling Time and Time to Biochemical Failure May Predict Prostate Cancer-Specific Mortality

• Read more..

Includes:

• Us TOO Names 2009 Board Officers & Members

• FDA Approves Ferring Pharmaceuticals’ Degarelix (generic name) for Advanced Prostate Cancer

• Geography’s Role in Medicare Cancer Coverage

• Low-Income Men More Often Diagnosed with Advanced Prostate Cancer

• FDA Commissioner to Step Down

• Us TOO Pleasanton, California Chapter Honors Memory of Bill Stone

• The Doctor’s Note—Dr. Gerald Chodak

• Read more..

Includes:

• Medicare Widens Drugs It Accepts for Cancer

• Experts Urge Prostate Cancer “Man-o-Gram’

• Prostate Cancer and Neglect of Other Illnesses

• Thalidomide for the Treatment of Biochemically Recurrent Prostate Cancer

• Adjuvant Radiotherapy Improves Survival after Radical Prostatectomy

• Donated Items Sought for June Online Auction

• Family History of Prostate Cancer Does Not Affect Treatment Outcomes

• Read more..

April | View Newsletter

MAY | View Newsletter

June | View Newsletter

Includes:

• Stop PSA Screening in Men Over 75 — But Only Those With Low PSA, Says New Study

• Researchers Identify Biomarker for Fatal Prostate Cancer

• Costs Force Cancer Survivors to Pass on Health Care

• Molecule’s Prevalence May Aid in Deciding Whether to Treat Prostate Cancer

• GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Safety Review

• Preventing Prostate Cancer: Good Nutrition May Be Key

• Personalized Calculator for Future Prostate Cancer Risk

• Read more..

Includes:

• What to Make of the Prostate Cancer Screening Studies

• A Joint Statement from America’s Prostate Cancer Advocacy, Education and Support Organizations

• Leading US-Based Prostate Cancer Organizations Develop Joint Policy Agenda

• PSA Has Higher Predictive Ability in Black Men than in White Men

• Highlights from the 2009 ASCO GU Cancers Symposium

• Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment

• The Doctor’s Note — Dr. Gerald Chodak

• Read more..

Includes:

• Urologists Support Baseline PSA Test at Age 40

• Provenge® Significantly Improves Survival

• Living and Loving with Prostate Cancer

• Us TOO Seeks Board Member Applications

• Statins May Protect Prostate Health

• Race May Not Be Key in Cancer Disparities

• Gene Variant Linked to Aggressive Cancers

• Agent Orange & Rapidly Recurrent Cancer

• NCI’s Plan to Accelerate Cancer Research

• Read more..

July | View Newsletter

August 

September

Includes:

• Signposts Brochure Now Available

• Young Men with Advanced Cancer & Prognosis

• False Positives in Screening Reduced by New Test

• Predicting Prostate Cancer Recurrence

• Combidex® & Lymph Node Metastasis

• Us TOO Seeks Board Member Applications

• Prostate Cancer Yet Another Worry for Women

• Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

• Read more..

October

November

December